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n mammalian cells, the centrosome consists of a pair of
centrioles and amorphous pericentriolar material. The
pair of centrioles, which are the core components of the
centrosome, duplicate once per cell cycle. Centrosomes
play a pivotal role in orchestrating the formation of the
bipolar spindle during mitosis. Recent studies have linked
centrosomal activity on centrioles or centriole-associated
structures to cytokinesis and cell cycle progression
through G1 into the S phase. In this study, we have iden-
I
 
tified centrobin as a centriole-associated protein that
asymmetrically localizes to the daughter centriole. The
silencing of centrobin expression by small interfering
RNA inhibited centriole duplication and resulted in cen-
trosomes with one or no centriole, demonstrating that
centrobin is required for centriole duplication. Further-
more, inhibition of centriole duplication by centrobin
depletion led to impaired cytokinesis.
 
Introduction
 
In mammalian cells, a pair of centrioles and amorphous peri-
centriolar material constitute the centrosome, which plays a
pivotal role in orchestrating formation of the bipolar spindle
during mitosis (Kellogg et al., 1994; Zimmerman et al., 1999;
Doxsey, 2001). Recent studies have demonstrated that cen-
trosome activity is linked to cytokinesis and the activation of
DNA replication (Hinchcliffe et al., 2001; Khodjakov and
Rieder, 2001; Piel et al., 2001). The latter activity, which is
physically associated with core centrosomal structures such as
the centrioles or with centriole-associated structures (Hinch-
cliffe et al., 2001), is probably distinct from the microtubule-
organizing activities of the centrosome.
In mammalian cells, the centrioles consist of nine triplets
of microtubules, arranged in a cylinder that has a 200-nm diam-
eter and an 
 
 
 
500-nm length, with additional filaments, fibers,
and dense material attached to or inside of the microtubular
cylinder (Doxsey, 2001; Beisson and Wright, 2003). In addi-
tion to 
 
 
 
/
 
 
 
-tubulin, only a small number of proteins have been
found to localize to the centrioles in mammalian cells. These
include centrin, 
 
 
 
-tubulin, centriolin, ninein, and poly(ADP-
ribose) polymerase-3 (Salisbury, 1995; Paoletti et al., 1996;
Chang and Stearns, 2000; Mogensen et al., 2000; Piel et al.,
2000; Ou et al., 2002; Augustin et al., 2003). The centrioles du-
plicate once per cell cycle in a manner similar to DNA replica-
tion. Centriole duplication starts at the onset of the S phase; the
two centrioles separate and a new (daughter) centriole forms in
association with the mother centriole (Rieder and Borisy, 1982;
Vorobjev and Chentsov Yu, 1982). However, exactly how this
protein-based structure duplicates accurately remains com-
pletely unknown. It has been clearly established that cen-
trosome duplication in mammalian somatic cells requires
CDK2 activity (Hinchcliffe et al., 1999; Lacey et al., 1999;
Meraldi et al., 1999). Recently, nucleophosmin, Mps1p, and
CP110 have been identified as centrosomal substrates of CDK2
and have also been shown to play an important role in the du-
plication of centrosomes (Okuda et al., 2000; Fisk and Winey,
2001; Chen et al., 2002).
The fidelity of mammalian cell division requires the pre-
cise segregation of genetic material into daughter cells, together
with a well orchestrated distribution of subcellular organelles.
Errors in this process are associated with genetic diseases and
underlie aneuploidy, which is a hallmark of cancer progression.
Normal centrosome duplication is a key requirement for the
correct segregation of chromosomes during cell division, and
the centrosome duplication cycle is tightly coupled to the cell
division cycle (Doxsey, 2001; for review see Hinchcliffe and
Sluder, 2001). Uncoupling of the centrosome duplication cycle
from the cell division cycle leads to more than two centrosomes
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per cell, i.e., centrosome amplification, which is a phenotype
frequently observed in both cultured tumor cells and a variety
of human tumors (Lingle et al., 1998, 2002; Pihan et al.,
1998, 2003; D’Assoro et al., 2002). Thus, the identification
and characterization of novel centrosomal proteins that regu-
late centrosomal duplication is an area of cell biological and
medical interest.
We have identified a novel daughter centriole–associ-
ated protein that we have designated centrobin (centrosomal
BRCA2 interacting protein). RNA interference (RNAi)–mediated
depletion of centrobin blocked centriole duplication and led to
centrosomes with one or no centriole, demonstrating that cen-
trobin is required for the assembly of the nascent centriole.
Inhibition of centriole duplication upon centrobin depletion led
to the impairment of cytokinesis. These studies identified a
novel component of the daughter centriole that is essential for
centriole duplication and function.
 
Results
 
Identification, expression, and 
characterization of centrobin
 
We identified centrobin in a yeast two-hybrid screening with
the conserved COOH-terminal 1,026 residues of BRCA2 as
bait. The yeast two-hybrid screening was performed as de-
scribed previously (Gao et al., 1999, 2000). One set of 11
positive clones encoded the COOH-terminal 539 aa and the
3
 
 
 
-untranslated region of centrobin (Fig. 1, C and E). Northern
blotting revealed a single centrobin mRNA transcript of 
 
 
 
3.8
kb expressed in most human tissues and all of the cell lines
tested, although the levels varied (Fig. 1, A and B). The basis
and significance of the interaction of centrobin with BRCA2 is
currently under investigation and is not discussed here.
Two rounds of 5
 
 
 
 rapid amplification of complementary
DNA (cDNA) ends PCR, using the human mammary gland
Marathon-Ready cDNA as a template, allowed us to clone the
5
 
 
 
 end of centrobin cDNA and to assemble a 3,718-bp cDNA
predicting a 903-aa polypeptide (Fig. 1 C). The size of this
cDNA, as well as the presence of several in-frame stop codons
5
 
 
 
 to the first in-frame methionine, indicates that this cDNA
represents the 3.8-kb transcript observed on the Northern blots
(Fig. 1, A and B). One cDNA library-derived clone revealed a
66-bp in-frame insertion after nucleotide 3433, predicting a
925-aa polypeptide (Fig. 1 D). This clone appears to represent
a minor transcript, given that only one of the nine sequenced
clones contained this 66-bp insertion. In addition, only one
EST clone in GenBank contains this insertion (available from
Genbank/EMBL/DDBJ under accession no. BM127046). The
3,718-bp transcript was designated as centrobin-
 
 
 
 (available
from Genbank/EMBL/DDBJ under accession no. AY160226)
and the 3,784-bp transcript as centrobin-
 
 
 
 (available from Gen-
bank/EMBL/DDBJ under accession no. AY160227). A search
of the National Center for Biotechnology Information database
indicated that centrobin is a unique protein. Weak homology
was observed between the central region of centrobin and vari-
ous coiled–coil proteins. Centrobin is predicted to have a
coiled–coil region at its center and noncoiled regions at the
COOH and NH
 
2
 
 termini, as do some known centrosomal pro-
teins such as pericentrin and ninein (Fig. 1 E).
To examine the expression and function of centrobin, we
generated an anti-centrobin antiserum against a His-tagged
fusion protein of the COOH-terminal 539 aa of centrobin. To
determine whether this antiserum specifically recognizes re-
combinant and endogenous centrobin, cell lysates from various
cell lines and 293T cells transfected with vector, Myc-tagged
centrobin, or GFP-tagged centrobin were analyzed by Western
Figure 1. Centrobin expression, amino acid
sequence, and structure. (A and B) A tissue
blot with 2  g of polyA mRNA per lane (A)
and a blot with 20  g of total mRNA from the
indicated breast cell lines (B) were probed
with a 
32P-labeled centrobin probe followed
by autoradiography. Hybridization with the
36B4 probe was used as a loading control.
(C) The predicted amino acid sequence of
centrobin- . (D) The extra 22 residues pre-
sented only in centrobin- . (E) Coiled–coil re-
gions of centrobin, ninein, and pericentrin as
predicted by DNASTAR. Boxes indicate the
coiled–coil region; lines indicate noncoiled re-
gions. Centrobin-C, the COOH-terminal frag-
ment of centrobin that was isolated from the
yeast two-hybrid screen. (F) Centrobin protein
expression. Cell lysate from the indicated cell
lines or 293T cells transfected with pCR3.1
vector, Myc-centrobin, or GFP-centrobin con-
structs were fractionated by a 6% SDS-PAGE
and blotted with affinity-purified anti-centrobin
or anti-Myc antibodies. 
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blotting using affinity-purified anti-centrobin antibody. Consis-
tent with the size of centrobin, the anti-centrobin antibody rec-
ognized a 100-kD protein in all cell lines tested (Fig. 1 F, lanes
3–9). As expected, we found that the level of this 100-kD pro-
tein is significantly higher in the Myc-centrobin–transfected
293T cells than in the vector-transfected cells (Fig. 1 F, lanes 3
and 4). Anti-Myc antibody specifically detected the 100-kD
band only in the Myc-centrobin–transfected cells (Fig. 1 F,
lane 2). The specificity of the antiserum was also demonstrated
by the presence of a 127-kD protein in the GFP-centrobin–
transfected 293T cells (Fig. 1 F, lane 5). Furthermore, preincu-
bating the antibody with purified His-centrobin significantly
diminished the specific signal detected by this antiserum (unpub-
lished data). These results demonstrate that the anti-centrobin
antiserum specifically detects endogenous centrobin and that
centrobin is ubiquitously expressed (Fig. 1 F and not depicted).
 
Localization of centrobin to the 
centrosome
 
The anti-centrobin antibody characterized in Fig. 1 F was used
to examine the localization of endogenous centrobin in a nor-
mal human mammary epithelial cell line (76N) and several
cancer cell lines (T47D, MCF-7, and Capan-1). A typical cen-
trosomal staining pattern was observed in all the cell lines
tested, with one or two perinuclear dots in the interphase cells
(Fig. 2 A, g, o, and s) and a single focus at the end of each mi-
totic spindle in mitotic cells (Fig. 2 A, c and k). The centrobin
staining pattern was similar to that of 
 
 
 
-tubulin, a protein
known to specifically localize to centrosomes (Fig. 2 A, d, h, p,
and t). An identical centrosomal staining pattern was observed
in MCF10A, HeLa, COS-7, and 293T cells (unpublished data).
The centrosomal staining was observed under three different
fixation conditions (3.7% formaldehyde, 100% methanol, or
0.5% glutaraldehyde) and also when cells were extracted with
0.5% Triton X-100 in 80 mM Pipes, 1 mM MgCl
 
2
 
, and 5 mM
EGTA, pH 6.8, before fixation. Furthermore, the centrosomal
localization of centrobin was not affected by treatment with no-
codazole (unpublished data). These findings strongly indicated
that centrobin is likely to be a bona fide core component of the
centrosomes (Oegema et al., 1995). Importantly, GFP-cen-
trobin and Myc-centrobin also localized to the centrosomes in
the transfected cells when they were expressed at a very low
level (Fig. 2, B and C). It is notable that both GFP-centrobin
and Myc-centrobin formed bundle-like structures when ex-
pressed at high levels, which is probably an artifact of high-level
expression because the endogenous centrobin is expressed at
very low levels and is found mainly on centrosomes (unpub-
lished data). A truncated Myc-tagged centrobin (centrobin-C;
encoding the COOH-terminal 539 aa) also localized to the cen-
trosomes when expressed at low levels (Fig. 2 D), indicating
Figure 2. Localization of centrobin to the centrosomes. (A) Endogenous centrobin localized to the centrosomes. T47D, MCF-7, 76N, and Capan-1 cells
were grown on coverslips, fixed with cold methanol, stained with affinity-purified anti-centrobin (1  g/ml) and anti– -tubulin (1:500) or anti– -tubulin
(1:400), and stained with rhodamine-labeled goat anti–rabbit IgG and FITC-labeled goat anti–mouse IgG. DNA was stained with DAPI. (B) Localization
of GFP-tagged centrobin to the centrosomes. 76NTert cells were grown on coverslips, transfected with pEGFP-Myc-centrobin, fixed with cold methanol,
stained with anti– -tubulin (1:400), and stained again with rhodamine-labeled goat anti–mouse IgG. DNA was stained with DAPI. (C) Localization of Myc-
tagged centrobin to the centrosomes. 76NTert cells were transfected with pCR3.1-Myc–centrobin, fixed with cold methanol, and stained with anti-Myc
antibody 9E10 (1  g/ml) and anti– -tubulin (1:400), and then with rhodamine-labeled goat anti–mouse IgG and FITC-labeled goat anti–rabbit IgG.
DNA was stained with DAPI. (D) Localization of Myc-tagged centrobin-C to the centrosomes. 76NTert cells were grown on coverslips, transfected with
pSG5-Myc–centrobin-C, fixed with cold methanol, and stained with anti-Myc and anti– -tubulin antibodies (1:400). 
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that the COOH-terminal 539 aa of centrobin is sufficient for
centrosomal localization. It is noteworthy that when Myc–
centrobin-C was expressed at a high level it decorated the
microtubules, which is also probably an artifact of high-level
expression (unpublished data).
To corroborate our observation that centrobin localizes to
the centrosomes, using immunofluorescence analysis, we
biochemically purified the centrosomes from 293T cells us-
ing sucrose-gradient sedimentation (Blomberg-Wirschell and
Doxsey, 1998) and analyzed their compositions by Western
blotting. As shown in Fig. 3, centrobin was found in the frac-
tions that were expected to contain the centrosomes, as con-
firmed by the presence of 
 
 
 
-tubulin in these fractions (Fig. 3,
top two panels). Similar data were obtained using MCF7 cells,
which are human breast cancer cells (unpublished data). The
centrosomal fractions were shown to be free of nuclear and cy-
toplasmic contamination by Western blotting using Lamin B1
as a nuclear marker and Cbl as a cytoplasmic marker (Fig. 3,
bottom two panels). Collectively, the immunofluorescence and
biochemical studies unequivocally demonstrated that centrobin
is a centrosomal protein.
 
Centrobin localizes to daughter centrioles
 
During our initial immunolocalization analyses we noted that
the staining pattern of centrobin differed in cells that appeared
to be at different phases of the cell cycle, suggesting the possi-
bility that centrobin may differentially localize in either the
mother or daughter centrioles. To further explore this possibil-
ity, we performed centrobin localization experiments in syn-
chronized 76NTert cells (an hTert immortalized cell line de-
rived from normal human mammary epithelial 76N cells) in
which the two centrioles were typically located farther apart
from each other than they are in other cells. Synchronization
was achieved by mitotic shake-off. A majority of cells at G0/G1
exhibited a strongly stained centriolar dot, with the other cen-
triole stained weakly or not at all with anti-centrobin antibody.
Superimposing centrin and centrobin staining essentially dem-
onstrated complete correspondence of weak centrin staining
(daughter centriole) with strong centrobin staining, and vice
versa (Fig. 4 A). In the majority of G1/S, S, and G2/M phase
cells, there are usually two strongly stained centrobin dots, cor-
relating with the two newly synthesized daughter centrioles, as
indicated by the weaker centrin-2 staining. In some cells, three
or four centrobin dots can also be found, including one or two
dots with weaker centrobin staining, which are likely to corre-
late with the original daughter centrioles (mother centrioles, in
the current duplication cycle). These findings indicate that cen-
trobin is preferentially incorporated into the newly assembled
daughter centriole during centriole assembly at the late G1 or
early S phase and that centrobin remains in the daughter centri-
oles throughout the cell cycle. At the next cycle of centriole
Figure 3. Copurification of centrobin with the centrosomes through sucrose
gradients. Centrosomes from 293T were purified through a 40–70% sucrose
gradient as described (Blomberg-Wirschell and Doxsey, 1998). The result-
ing fractions were separated on SDS-PAGE gels and blotted with anti-
centrobin, anti– -tubulin, anti-Lamin B1, and anti-Cbl antibodies.
Figure 4. Centrobin localized to the daughter centriole. (A) Localization
of centrobin during different phases of the cell cycle in 76NTert cells.
76NTert cells were synchronized by mitotic shake-off and replating. Cells
were harvested, extracted, fixed with cold methanol, and stained with
anti-centrobin (red) and anti–centrin-2 (green) antibodies. (B) Centrobin lo-
calization in interphase NIH-3T3 cells. The cells were fixed with cold meth-
anol, and then stained with anti-acetylated  -tubulin (green) and anti-
centrobin  (red) antibodies. (C) Centrobin localization in U2OS cells
treated with HU. U2OS cells were treated with 16 mM HU for 72 h, fixed
with cold methanol, and stained with anti-centrobin (red) and anti–centrin-2
(green) antibodies. (D) Immunogold electron microscopic localization of
centrobin on the daughter centrioles. 10-nm gold particles were detected
on daughter centrioles (D) but not on mother centrioles (M). 
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duplication, the amount of centrobin on the original daughter
centriole eventually decreases, as shown in the G1/S and S
phase cells (Fig. 4 A).
To corroborate these observations, we performed double-
immunofluorescence localization of centrobin and acetylated
 
 
 
-tubulin in NIH-3T3 cells. Previous studies have shown that in
G0/G1 phase a primary cilium grows from the mother centriole
in NIH-3T3 cells and that this cilium can be stained with anti-
acetylated 
 
 
 
-tubulin antibody (Albrecht-Buehler and Bushnell,
1980; Rieder and Borisy, 1982; Piperno and Fuller, 1985; Lange
and Gull, 1995). As shown in Fig. 4 B, anti-centrobin staining
clearly superimposed with the centriole without the primary cil-
ium, the daughter centriole. We also analyzed U2OS cells treated
with hydroxy urea (HU) for 72 h, a treatment known to induce
extensive centrosome amplification (Stucke et al., 2002). As
shown in Fig. 4 C, anti-centrobin staining always superimposed
with the centrioles with the weaker centrin staining, i.e., the
newly synthesized centrioles (Fig. 4 C).
To further characterize the localization of centrobin on
the centrioles, we performed immunogold electron micros-
copy. Nuclear–centrosome complexes were prepared according
to the Kuriyama method (Kuriyama and Borisy, 1981) and
embedded in LR white resin. Thin sections were incubated
with anti-centrobin antibody, followed by incubation with
gold-conjugated  anti–rabbit secondary antibodies. As in our
immunofluorescence studies, centrobin clearly localized to the
daughter centrioles, which are the centrioles without the char-
acteristic appendage structure of the mother centriole (Fig. 4 D).
We found that centrobin mainly localizes outside of the triplet
microtubule blades of the daughter centriole (Fig. 4 D). Some
centrobin staining was also found in the lumen and on the
triplet microtubule blades of the daughter centriole (Fig. 4 D).
Together, these results strongly indicate that centrobin prefer-
entially localizes to the daughter centriole.
 
Centrobin is required for centriole 
duplication
 
We used 21-nt small interfering RNA (siRNA) targeting the
coding region of centrobin to knock down centrobin expres-
sion. As shown in Fig. 5 A, the endogenous centrobin level
was markedly reduced after centrobin siRNA transfection of
HeLa cells, but not after the scrambled siRNA and GFP-
siRNA were transfected (Fig. 5 A, top). Transfection of HeLa
cells with FITC-labeled GFP-siRNA indicated a transfection
efficiency of 
 
 
 
90%. Densitometry analysis of the Western
blots indicated that 80% of centrobin was reproducibly de-
pleted with centrobin RNAi #1, which we used in all subse-
quent experiments. The reduction of centrobin levels was also
confirmed by immunofluorescence analysis (Fig. 5 B). Immuno-
fluorescence analysis with anti–
 
 
 
-tubulin antibodies revealed
that the 
 
 
 
-tubulin staining pattern was not visibly altered in the
HeLa cells with undetectable levels of centrobin (Fig. 5 C).
Furthermore, no gross abnormalities in microtubule nucleation
and organization was observed in centrobin-depleted cells
(Fig. 5 D), suggesting that centrobin likely does not substan-
tially contribute to microtubule organization and nucleation, at
least in interphase cells.
To examine the function of centrobin in centriole duplica-
tion, we enumerated the centrioles in control RNAi-treated ver-
sus centrobin-depleted HeLa cells using anti–centrin-2 staining.
In centrobin-depleted cultures, 21% of interphase cells had four
centrioles, 67% had two centrioles, 7% had one centriole, and
2% had no centriole (Fig. 6 A). In contrast, among the control
HeLa cells, 47% of the interphase cells had four centrioles, 47%
had two centrioles, only 2% of interphase cells had one centriole,
Figure 5. Centrobin depletion did not affect the localization of  -tubulin
or microtubule organization and nucleation. (A) Western blot analysis of
HeLa cells transfected with centrobin siRNA or control siRNA. HeLa cells
were transfected with control (scrambled or FITC-GFP siRNA) or two-cen-
trobin siRNA. After 72 h, cells were harvested and separated through a
6% SDS-PAGE, then blotted with anti-centrobin and anti– -tubulin antibod-
ies. (B) Immunostaining of centrobin. HeLa cells transfected with scram-
bled or centrobin siRNA #1 were stained with anti-centrobin and
rhodamine-labeled goat anti–rabbit IgG. DNA was stained with DAPI. (C)
Centrobin depletion did not affect the localization of  -tubulin. HeLa cells
transfected with scrambled or centrobin siRNA #1 were stained with anti-
centrobin and anti– -tubulin and with rhodamine-labeled goat anti–rabbit
IgG and FITC-labeled goat anti–mouse IgG. (D) Centrobin depletion did
not affect microtubule organization and nucleation. HeLa cells were trans-
fected with scrambled siRNA or centrobin siRNA; after 72 h, the cells
were treated with 1  M nocodazole for 1 h and washed three times with
PBS to remove the nocodazole. The cells were harvested for fixation using
cold methanol and stained for  -tubulin at 0, 2, 5, 10, and 15 min after
the removal of nocodazole. 
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and 0.3% had no centriole (Fig. 6 A). Thus, centrobin depletion
induced a marked reduction in the proportion of cells with four
centrioles and, correspondingly, an increase in the proportion of
cells with fewer than four centrioles. An even more pronounced
difference was seen in mitotic cells. Essentially all mitotic cells
in the control culture had four centrioles; in contrast, only 51%
of the centrobin-depleted mitotic cells had four centrioles,
whereas 45% had two and 4% had one centriole (Fig. 6 B).
Thus, RNAi-mediated centrobin depletion dramatically inhib-
ited centriole duplication. Nevertheless, the cells were still able
to progress through the cell cycle, at least once or twice, gener-
ating cells with one centriole or none.
To confirm that the anti–centrin-2 staining dots indeed
represent centrioles, we costained the cells with anti–
 
 
 
-tubulin
and anti–centrin-2 after the cells were cold treated and deter-
gent extracted to depolymerize the microtubules. We found
that anti–centrin-2 staining correlated well with anti–
 
 
 
-tubulin
staining (unpublished data). And the centriole number assessed
by anti–
 
 
 
-tubulin staining correlated with the centriole number
assessed by anti–centrin-2 staining. We also examined the
number of centrioles in control and centrobin-depleted cells using
electron microscopy. By examining consecutive thick sections
spanning entire nucleus–centrosome complexes, we discovered
that out of 58 centrobin-depleted cells examined, 1 cell had 5
centrioles, 15 cells had 4 centrioles, 34 cells had 2 centrioles, 5
cells had 1 centriole, and 3 cells had no centriole. A total of 33
control cells were also examined, and out of these 1 cell had 6
centrioles, 19 cells had 4 centrioles, 13 cells had 2 centrioles,
and 0 cells had 1 or no centriole. This finding is similar to what
was observed using anti–centrin-2 staining. Our observation of
cells with one or no centriole in centrobin-depleted cells but
not in control cells clearly indicated that centrobin depletion
inhibited centriole duplication, confirming our finding using
anti–centrin-2 staining dots to represent centrioles.
To test whether centrobin depletion directly inhibits cen-
triole duplication, we examined the effect of centrobin depletion
on HeLa cells arrested in the S phase. 48 h after siRNA trans-
fection, the cells were exposed to HU for 24 h to induce S phase
arrest. The cells were incubated for 30 min with BrdU, har-
vested, and stained with anti-BrdU and anti-centrobin antibodies.
BrdU staining demonstrated that 94% of the control cells and
85% of the centrobin-depleted cells were arrested in the S
phase, indicating that centrobin-depleted cells are still able to
enter S phase (Fig. 6 D). Because centriole duplication occurs
during the late G1 and S phases, all cells arrested in the S phase
should contain four centrioles. Indeed, a majority (
 
 
 
87%) of
the control RNAi-transfected cells contained four centrioles
(Fig. 6 E); only 9% of these cells had fewer than four centrioles.
Figure 6. Centrobin depletion inhibited centrosome duplication.
(A and B) Centrobin depletion inhibited centrosome duplication
in interphase and mitotic HeLa cells. HeLa cells were transfected
with scrambled siRNA or centrobin siRNA and, 72 h later, were
fixed with cold methanol and stained with anti-centrobin and
anti–centrin-2 antibodies. The number of centrioles was counted
according to the centrin-2 staining in interphase (A) and mitotic
cells (B) with an undetectable level of centrobin. Data presented
are the percentages of cells with more than four, four, two, one,
or zero centrioles (average from three independent experiments).
For interphase cells, 300 cells were counted in every experiment.
For mitotic cells, 100 cells were counted in every experiment. (C)
Electron microscopic examination of centrosomes from control or
centrobin-depleted HeLa cells over consecutive thick sections
spanning the entire nuclear–centrosome complexes. A represen-
tative control cell with two centrioles and a centrobin-depleted
cell with one centriole are shown here. (D and E) Centrobin de-
pletion inhibited centriole duplication in HeLa cells arrested by
HU. HeLa cells were transfected with scrambled siRNA or cen-
trobin siRNA. 48 h later the cells were treated with16 mM HU
for another 24 h, pulse-labeled with BrdU for 30 min, and fixed
and stained with anti-BrdU and anti-centrin. Data presented in D
are the percentage of cells with four, two, one, or zero centrioles
(average from three independent experiments with 300 cells
counted in every experiment). Data presented in E are the per-
centages of cells with positive or negative BrdU staining (aver-
age from three independent experiments with 300 cells counted
in every experiment). (F) Centrobin depletion inhibited cen-
trosome overamplification in U2OS cells treated with HU. U2OS
cells were either treated with HU for 16 h, then transfected with
scrambled siRNA or centrobin siRNA, and incubated for an ad-
ditional 48 h in the presence of 16 mM HU (HU→siRNA) or
transfected with scrambled siRNA or centrobin siRNA, and 8 h
later treated with 16 mM HU for an additional 62 h (siRNA→HU).
All cells were fixed and stained with anti-centrobin and anti–
 -tubulin antibodies. Data presented are the percentages of cells
with more than two centrosomes (average and SD from three
independent experiments with 300 cells counted in every experi-
ment). (G) Representative U2OS cells transfected with control or
centrobin siRNA. 
CENTROBIN IS REQUIRED FOR CENTROSOME DUPLICATION • ZOU ET AL.
 
443
 
In contrast, only 48% of the centrobin-depleted cells contained
four centrioles, and 50% contained fewer than four centrioles
(vs. 9% of control cells; Fig. 6 E). These experiments demon-
strated that the majority of centrobin-depleted cells are able to
enter the S phase, but are unable to undergo centriole duplica-
tion. Therefore, the inhibition of centriole duplication upon cen-
trobin depletion is not a consequence of cell-cycle arrest.
Furthermore, we examined the effect of centrobin deple-
tion in U2OS cells. It has been reported that, upon prolonged S
phase arrest by HU, the centrosomes in these cells become
overamplified (Stucke et al., 2002). If the effect of centrobin
depletion on centrosome duplication was a consequence of pre-
venting cells from entering the S phase, then centrobin RNAi
would be expected to be effective only when it was transfected
into cells before HU treatment (Meraldi et al., 1999). On the
other hand, if centrobin has a direct role in centrosome duplica-
tion, then centrobin RNAi would be expected to inhibit centri-
ole duplication even when it is introduced into cells after S
phase arrest. As shown in Fig. 6 F, centrosome overamplifica-
tion was inhibited to a similar extent regardless of whether cen-
trobin RNAi was introduced into U2OS cells before or after S
phase arrest. We found that 
 
 
 
52% of the cells transfected with
control siRNA had overamplified centrosomes, whereas only
21% of the cells transfected with centrobin siRNA had overam-
plified centrosomes. Together, these findings clearly indicate
that centrobin is required for centriole duplication.
 
Centrobin depletion leads to impaired 
cytokinesis
 
When centrobin was depleted in HeLa cells by the use of siRNA,
we observed that the percentage of cells with two or more nuclei
increased significantly (from 3% in control siRNA-transfected
cells to 20% in the centrobin-depleted cells), indicating a failure
of cytokinesis in a proportion of the centrobin-depleted cells
(Fig. 7, A and B). To further explore this finding, we directly ex-
amined the progression of cell division with time-lapse micros-
copy. For this purpose, HeLa cells were transfected with control
or centrobin siRNA. Phase-contrast time-lapse microscopy was
initiated 8 h later and continued for 48 h (Videos 1 and 2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200506185/DC1).
In the control cultures, 15 of the 23 observed cells completed mi-
tosis within 2 h, and 22 of the 23 cells completed mitosis within
4 h; no cell failed to complete cytokinesis (Fig. 7, C and D). In
contrast, out of the centrobin siRNA-transfected cells that went
into mitosis, only 2 of 15 observed cells completed mitosis
within 2 h, and only 5 of 15 cells completed mitosis within 4 h;
6 of 15 cells failed to do so within 4 h and 4 of 15 cells exited
mitosis without finishing cytokinesis. This finding indicates that
centrobin depletion impairs cytokinesis.
 
Discussion
 
We have identified a novel protein, centrobin, which harbors a
large coiled–coil domain. We have demonstrated that cen-
trobin is a bona fide core component of the centrosomes.
Through detailed analysis of centrobin localization we have
established that centrobin asymmetrically localizes to the
daughter centrioles. To our knowledge, only poly(ADP-ribose)
polymerase-3 has been reported to localize preferentially to
the daughter centriole (Augustin et al., 2003). Further studies
to identify the binding partners of centrobin will likely reveal
more proteins that preferentially localize to the daughter cen-
trioles, which should eventually help to elucidate the mecha-
nism of centriole duplication.
It is of particular importance that the depletion of cen-
trobin in HeLa cells resulted in a high percentage of both inter-
phase and mitotic cells that had two, one, or no centrioles, even
under the condition of S phase arrest, which indicates that cen-
trobin depletion inhibits the duplication of centrioles. Further
analysis in U2OS cells arrested by HU treatment confirmed
Figure 7. Centrobin depletion led to impaired cytokinesis. (A) Centrobin
depletion led to cells with multiple nuclei. HeLa cells were transfected with
scrambled siRNA or centrobin siRNA and, 72 h later, stained with anti-
centrobin and DAPI (blue). The percentage of cells with two or more nuclei
was enumerated. Data presented are averages and SDs from three inde-
pendent experiments with 300 cells counted in every experiment. (B) Rep-
resentative HeLa cells with two or four nuclei. (C) Centrobin depletion led
to impaired cytokinesis. HeLa cells were transfected with scrambled siRNA
or centrobin siRNA. 8 h after transfection, time-lapse phase-contrast mi-
croscopy was initiated and continued for 48 h. All the cells that underwent
cytokinesis were followed to determine the fate and duration of cell divi-
sion (from cell roundup until two daughter cells separate). The data pre-
sented were compiled from two experiments. The durations of cell division
for the 23 control cells are 50, 55, 65, 65, 70, 75, 80, 80, 80, 85, 90,
100,100, 105, 110, 140, 160, 165, 170, 180, 200, 220, and 450
min. The durations of cell division for the 11 centrobin-siRNA–transfected
cells are 85, 115, 135, 135, 220, 270, 335, 600, 640, 645, and 665
min. Four centrobin-siRNA–transfected cells exited mitosis without finishing
cytokinesis at 175, 190, 210, and 260 min. (D) Two representative HeLa
cells, one transfected with centrobin siRNA and one with control siRNA
that underwent mitosis. The centrobin–siRNA-transfected cell was in mitosis
for   260 min and exited without finishing mitosis. The control siRNA
transfected cells took  120 min to finish mitosis. 
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that inhibition of centriole duplication induced by centrobin
depletion was not a consequence of cell cycle arrest. These
findings have clearly established that centrobin is required for
centriole duplication. The exact role of centrobin during centri-
ole duplication remains to be determined. Because CDK2 ac-
tivity has been shown to be required for centriole duplication
(Hinchcliffe et al., 1999; Lacey et al., 1999; Meraldi et al.,
1999), it will be of interest to examine if centrobin is a down-
stream target of CDK2.
We also found that 
 
 
 
-tubulin localization to the cen-
trosomes is not visibly affected in centrobin knockdown cells.
Furthermore, centrobin depletion does not appear to affect micro-
tubule organization and nucleation visibly in interphase cells.
However, we cannot exclude the possibility that centrobin plays a
role in the assembly of mitotic spindles, although we did not ob-
serve any conspicuous centrobin staining on the mitotic spindles.
We have also demonstrated that the inhibition of centri-
ole duplication by centrobin depletion leads to the lengthening
of mitosis and failure of cytokinesis in a substantial population
of cells. The impairment of cytokinesis induced by centrobin
depletion is reminiscent of the phenotypes observed in cells
when centrosomes were microsurgically removed or laser ab-
lated (Hinchcliffe et al., 2001; Khodjakov and Rieder, 2001).
In those studies, the majority of acentrosomal cells were still
able to undergo mitosis but took significantly longer to com-
plete cytokinesis, with a high percentage of cells failing to
complete cytokinesis. However, the mechanism of centrobin
depletion–induced impaired cytokinesis remains to be deter-
mined. Because we did not monitor the status of the centrosome
in the recorded cells, we cannot differentiate the effects of
centrobin directly on cytokinesis versus impaired cytokinesis
because of the formation of acentrosomal spindles.
Thus, centrobin, among a few known centrosome pro-
teins, has a particularly important function in orchestrating cen-
triole duplication. Additional structural and functional analyses
are likely to elucidate the mechanistic basis of a fundamental
aspect of cell biology, namely, centrosome duplication.
 
Materials and methods
 
Cells and media
 
MCF-7, T47D, U2OS, NIH-3T3, and HeLa cells were grown in 
 
 
 
-MEM
(Life Technologies) supplemented with 10% FCS (Hyclone). COS-7 and
293T cells were grown in DME (Life Technologies) supplemented with
10% FCS. Breast epithelial cell strain 76N cells, immortal derivative
76NTert cells, and MCF10A cells were grown in DFCI-1 medium (Band
and Sager, 1989).
 
Yeast two-hybrid constructs and screening
 
The cDNA encoding the COOH-terminal 1,026 residues of BRCA2 was
cloned into pGBKT7 (CLONTECH Laboratories, Inc.) to generate the bait
plasmid pGBKT7-BRCA2-C3. Yeast two-hybrid screening was performed
as previously described (Gao et al., 1999, 2000).
 
Plasmid constructs and siRNA
 
The centrobin fragment isolated from the yeast two-hybrid library was cloned
into a modified pSG5 vector, pGEX2TK, and into pPROEX Hta to generate
Myc-centrobin–C, GST-centrobin–C, and His-centrobin–C. The full-length un-
tagged, Myc-tagged, and GFP-tagged centrobin were constructed by PCR
and restriction splicing. The full-length centrobin constructs (untagged, Myc-
tagged, and GFP-tagged) used in this study represent centrobin-
 
 
 
. The cen-
trobin-C construct used in this study contains the extra 66-bp of centrobin 
 
 
 
.
It is referred to only as centrobin elsewhere in this paper.
The siRNAs were synthesized by Dharmacon, Inc. The sequence of
centrobin siRNA #1 was AGUGCCAGACUGCAGCAACTT and the se-
quence of centrobin siRNA #2 was CAACUGGACAAGACCCUGGTT.
The sequence of FITC-GFP siRNA was GGCTACGTCCAGGAGCGCACC
and the sequence of the scrambled siRNA was CAGTCGCGTTTGC-
GACTGG. The siRNA transfection was performed with Oligofectamine
(Invitrogen) as per the manufacturer’s instructions.
 
Immunofluorescence
 
Cells grown on coverslips (Fisher Scientific) were fixed in 3.7% PFA/
PBS for 10 min at RT, permeabilized in 0.5% Triton X-100/PBS, blocked
with 10% goat serum in PBS, and incubated with anti-centrobin, anti-
Myc (9E10), anti–
 
 
 
-tubulin, or anti–
 
 
 
-tubulin (Sigma-Aldrich) in 10%
goat serum/PBS. The primary antibodies were detected with FITC or rho-
damine-conjugated goat anti–rabbit IgG or goat anti–mouse IgG (The
Jackson Laboratory) and the DNA was stained with DAPI. Cells were
also fixed in ice-cold methanol for 10 min, in which case the permeabili-
zation step was eliminated. A fixation solution of 0.5% glutaraldehyde
was also used. An extraction step before fixation with 0.5% Triton X-100
in 80 mM Pipes, 1 mM MgCl
 
2
 
, and 5 mM EGTA, pH 6.8, was added in
some experiments. Gray level images were acquired using a charge-
coupled device camera (model ORCA-ER; Hamamatsu) mounted on an
epifluorescence microscope (Nikon) and pseudocolored using Adobe
Photoshop software.
 
EM 
 
For immuno-EM, centrosome–nuclear complexes were enriched according
to the method described by Kuriyama and Borisy (1981). In brief, 70–80%
confluent HeLa cells were scraped off of the culture dishes and pelleted.
The cells were resuspended in 10 vol of distilled water for 1 min, an equal
volume of lysis buffer (2 mM Hepes and 4% Triton X-100) was added,
and the sample was incubated for an additional 5 min. An equal volume
of 8% PFA plus 1% glutaraldehyde was added to fix the sample for 15
min at RT. The fixed samples were washed 3 times with Hepes buffer (20
mM Hepes, pH 7.4), dehydrated, and embedded in LR white resin (Ted
Pella, Inc.). Thin sections were blocked in blocking buffer (20 mM Hepes,
1% fish gelatin, and 0.4% Triton X-100) at RT for 1 h and incubated with
anti-centrobin antibody in blocking buffer (0.5 
 
 
 
g/ml) at 4
 
 
 
C overnight,
followed by incubation with goat anti–rabbit IgG conjugated with 10-nm
gold particles (Ted Pella, Inc.) for 2 h at RT. The thin sections were further
stained with saturated aqueous uranyl acetate and analyzed using a trans-
mission electron microscope (model CM-10; Philips).
To obtain serial thick sections, the purified nuclear–centrosome
complexes were fixed in 2.5% glutaraldehyde for 30 min, incubated in
2% osmium tetroxide for 10 min, incubated in 2% uranyl acetate for an-
other 10 min, and embedded in Embed 812. The samples were serially
thick-sectioned at 250 or 500 nm and analyzed using a transmission elec-
tron microscope (model JEOL-1234; Japan Electron Optics Laboratory
Co., Ltd.). A total of 58 centrobin knockdown cells were examined, of
which 47 cells were examined using 500-nm sections and 11 cells were
examined using 250-nm sections. A total of 33 control cells were exam-
ined using 500-nm sections.
 
Time-lapse imaging 
 
HeLa cells plated on 35-mm dishes with glass coverslip bottoms were
transfected with control siRNA or centrobin siRNA. 8 h after transfection,
the medium was replaced with CO
 
2
 
-independent medium (Invitrogen). The
cells were imaged every 5 min for 48 h using a 20
 
 
 
 phase-contrast lens
on an inverted microscope (model TE2000-U; Nikon) equipped with a
charge-coupled device camera controlled by Metamorph software (Univer-
sal Imaging Corp.). The microscope is enclosed in an incubator box (Life
Imaging Services) to maintain a temperature of 37
 
 
 
C.
 
Online supplemental material 
 
Videos 1 and 2 show that cells transfected with control and centrobin
siRNA underwent mitosis and that the silencing of centrobin expression
leads to impairment of cytokinesis. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200506185/DC1.
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